BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Business

  Trius Therapeutics Appoints Matthew Onaitis as General Counsel

  June 3, 2013

   · 

  1 min read
• Business

  Goodwin Biotechnology, Inc. Announces Process Development Sub-Contract for an Anthrax Vaccine

  June 3, 2013

   · 

  2 min read
• Genetown

  Synta Pharmaceuticals to Host Investor Meeting and Webcast at the 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  1 min read
• Biotech Bay

  Nektar Therapeutics (CA) Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  10 min read
• BioMidwest

  Transgenomic, Inc. and ApoCell, Inc. Present Results of Lung Cancer Research Study at the 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  1 min read
• MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  6 min read
• Drug Development

  Novartis Corporation Breakthrough Therapy LDK378 Shows a Marked Clinical Response in Patients With ALK+ Non-Small Cell Lung Cancer

  June 3, 2013

   · 

  8 min read
• Drug Development

  Celgene International Sárl Release: Analyses of MPACT Trial Evaluating ABRAXANE® Combination Therapy for the Treatment of Advanced Pancreatic Cancer Presented at American Society of Clinical Oncology 2013

  June 3, 2013

   · 

  1 min read
• AEterna Zentaris: Encouraging Final Data for Phase 1 Portion of Ongoing Phase 1/2 Trial with Zoptarelin Doxorubicin (AEZS-108) in Prostate Cancer Reported at American Society of Clinical Oncology

  June 3, 2013

   · 

  6 min read
• Drug Development

  CytRx Corporation Announces the Presentation of Favorable Results From Novel Combination of Aldoxorubicin and Doxorubicin in a Phase 1b Clinical Trial at American Society of Clinical Oncology Conference

  June 3, 2013

   · 

  1 min read